The strongest evidence is the fact that HPCs/oval cells are susceptible to neoplastic transformation, giving rise to HCC upon genetic alterations implying activation of oncogenes (such as Ras) or silencing of tumor suppressors (including ARF/INK4a and p53) [122,123,124,125]. The gene discussed is CDKN2A; the disease is hepatocellular carcinoma.